WebinarsNew
Deep DiveNew
Explore Business Standard
WebinarsNew
Deep DiveNew
Explore Business Standard
The revenue stands at ₹1,742.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.80 per cent from ₹1,695.36 crore. This corresponds to a year-on-year *(YoY) growth of 22.31 per cent.
Operating Profit stands at ₹513.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.97 per cent from ₹410.53 crore. This corresponds to a year-on-year *(YoY) growth of 47.62 per cent.
PBDT stands at ₹614.46 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.80 per cent from ₹469.78 crore. This corresponds to a year-on-year *(YoY) growth of 59.98 per cent.
Profit Before Tax stands at ₹505.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 39.67 per cent from ₹362.13 crore. This corresponds to a year-on-year *(YoY) growth of 75.42 per cent.
Net Profit stands at ₹366.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.23 per cent from ₹261.48 crore. This represents a 96.57 per cent year-on-year *(YoY) growth for the same year.
| Category | Q4 FY25-26 | Q4 FY24-25 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 1,742.79 | 1,424.91 | 22.31 | 6,430.65 | 5,616.50 | 14.50 |
| Expenses | 1,229.77 | 1,077.39 | 14.14 | 4,825.45 | 4,347.58 | 10.99 |
| Other Income | 111.47 | 44.03 | 153.17 | 316.33 | 213.61 | 48.09 |
| Operating Profit | 513.02 | 347.52 | 47.62 | 1,921.53 | 1,482.53 | 29.61 |
| Depreciation | 108.66 | 95.76 | 13.47 | 423.67 | 377.87 | 12.12 |
| Interest | 10.03 | 7.45 | 34.63 | 33.28 | 42.00 | -20.76 |
| Profit Before Tax | 505.80 | 288.33 | 75.42 | 1,464.58 | 1,062.66 | 37.82 |
| Tax | 139.12 | 101.79 | 36.67 | 458.86 | 371.97 | 23.36 |
| Net Profit | 366.68 | 186.54 | 96.57 | 1,027.32 | 698.53 | 47.07 |
| Category | Q4 FY25-26 | Q4 FY24-25 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 1,261.59 | 1,030.35 | 22.44 | 4,552.09 | 4,116.15 | 10.59 |
| Expenses | 753.88 | 636.23 | 18.49 | 2,913.36 | 2,673.53 | 8.97 |
| Other Income | 106.36 | 43.72 | 143.28 | 303.90 | 215.08 | 41.30 |
| Operating Profit | 1,262.64 | 991.37 | 27.36 | 1,942.63 | 1,657.69 | 17.19 |
| Depreciation | 43.11 | 43.07 | 0.09 | 176.24 | 169.27 | 4.12 |
| Interest | 6.17 | 3.45 | 78.84 | 18.07 | 22.84 | -20.88 |
| Profit Before Tax | 564.79 | 391.32 | 44.33 | 1,748.31 | 1,465.58 | 19.29 |
| Tax | 144.34 | 101.32 | 42.46 | 452.59 | 366.71 | 23.42 |
| Net Profit | 420.45 | 290.00 | 44.98 | 1,299.55 | 1,089.75 | 19.25 |
| Category | Q4 FY25-26 | Q3 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 1,742.79 | 1,695.36 | 2.80 |
| Expenses | 1,229.77 | 1,284.83 | -4.29 |
| Other Income | 111.47 | 63.17 | 76.46 |
| Operating Profit | 513.02 | 410.53 | 24.97 |
| Depreciation | 108.66 | 107.65 | 0.94 |
| Interest | 10.03 | 3.93 | 155.22 |
| Profit Before Tax | 505.80 | 362.13 | 39.67 |
| Tax | 139.12 | 100.65 | 38.22 |
| Net Profit | 366.68 | 261.48 | 40.23 |
| Category | Q4 FY25-26 | Q3 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 1,261.59 | 1,177.51 | 7.14 |
| Expenses | 753.88 | 780.23 | -3.38 |
| Other Income | 106.36 | 60.21 | 76.65 |
| Operating Profit | 1,262.64 | 1,085.45 | 16.32 |
| Depreciation | 43.11 | 44.53 | -3.19 |
| Interest | 6.17 | 0.50 | 1134.00 |
| Profit Before Tax | 564.79 | 412.46 | 36.93 |
| Tax | 144.34 | 104.61 | 37.98 |
| Net Profit | 420.45 | 307.85 | 36.58 |
Data not available.
| Company | 1 Day | 1 Week | 1 Month | 3 Months | 6 Month | 1 Year |
|---|---|---|---|---|---|---|
| Gland Pharma | 2.42% | 3.20% | 8.26% | 38.72% | 42.73% | 37.55% |
| Abbott India | -0.83% | -1.07% | 0.60% | -0.82% | 2.43% | -16.52% |
| Anthem Bioscienc | 1.49% | 4.25% | 14.19% | 8.85% | 23.36% | 13.23% |
| Glaxosmi. Pharma | 0.40% | -1.67% | 7.70% | 6.87% | -3.61% | -3.15% |
| Ajanta Pharma | 0.63% | -0.35% | 2.52% | 14.52% | 20.79% | 32.57% |
| Ipca Labs. | -2.46% | 0.71% | -7.12% | 10.49% | 18.20% | 26.69% |
| Emcure Pharma | 1.16% | 1.16% | 11.58% | 19.15% | 33.50% | 44.06% |
No More Data
More